Simultaneous administration of imipenem/cilastatin/relebactam with selected intravenous antimicrobials, a stewardship approach

Ghazi, IM; El Nekidy, WS; Asay, R; Fingmori, P; Knarr, A; Awad, M

Ghazi, IM (corresponding author), Univ Sci, Philadelphia Coll Pharm, Philadelphia, PA USA.

PLOS ONE, 2020; 15 (5):

Abstract

Imipenem/cilastatin/relebactam is a beta-lactam/beta-lactamase inhibitor that has been recently FDA approved for complicated intra-abdominal and urina......

Full Text Link